戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ells transformed with simian virus 40 (SV40) T antigen.
2 n small T antigen (sTAg) and truncated large T antigen.
3 origin-binding domain of virus-encoded large T antigen.
4 ernatively spliced 57kT forms of MCPyV large T antigen.
5  genome has undergone mutations in the large T antigen.
6 tent expression of large T antigen and small T antigen.
7 D patients were transformed using SV40 large T antigen.
8  of the role of simian virus 40 (SV40) small t antigen.
9 sion in mice that express the Polyoma middle T antigen.
10  MCC tumors that fail to express MCPyV large T antigen.
11 xpresses small T antigen and truncated large T antigen.
12 nd in only 1 of 56 tumors positive for large T antigen.
13 arrying the gene encoding the polyoma middle T antigen.
14 ion between PNA and glycoproteins containing T antigen.
15  methylation, and John Cunningham (JC) virus T antigen.
16 an essential step in unwinding origin DNA by T antigen.
17 mune response to peptides encoding BKV large T antigen.
18 cificity for conserved epitopes of JCV large T antigen.
19  Golgi, resulting in the formation of sialyl-T antigen.
20 ncy was the principal carcinogenic effect of T-antigen.
21 y of MCCs, may drive tumorigenesis via viral T antigens.
22 ost tumors express the MCPyV large and small T antigens.
23 mian virus 40 (SV40) large (T) and small (t) T antigens.
24 y test both tumor-derived and wild type (WT) T antigens.
25 r MUC1 carrying one or more Tn, T, or sialyl-T antigens.
26 spect to the early gene products, the tumor (T) antigens.
27 imeric reporters containing the entire BPCV1 T antigen 3' UTR undergo negative regulation when coexpr
28 eased in proportion to the reduction in p68N-T antigen affinity, confirming that p68-T antigen intera
29             Other polyomavirus-encoded large T antigens also increase the levels of CBP/p300 and sust
30  delayed in NHAs, and the expression of SV40 T antigen alters the cellular environment, which impacts
31  subunits as well as for the localization of T antigen and damage-signaling proteins to viral replica
32 nd viral oncogenes, including the SV40 large T antigen and human papilloma virus 16 E6-antigen.
33 mmortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OS
34 ing partner of the mouse polyoma virus large T antigen and later shown to possess tumor suppressor-li
35  of a kinase activity associated with middle T antigen and our serendipitous discovery that this acti
36    On the other hand, SVST complements large T antigen and Ras for the transformation of human mammar
37          It is predicted to encode the large T antigen and small T antigen early proteins and the VP1
38 yomavirus and persistent expression of large T antigen and small T antigen.
39  The fraction of cells expressing SV40 large T antigen and the levels of T antigen mRNA were reduced
40 helicases, such as the simian virus 40 large T antigen and the papillomavirus E1 protein, are active
41 hromosomes of MCC tumors and expresses small T antigen and truncated large T antigen.
42 rocytes, which instead expressed early viral T antigens and exhibited apoptotic death.
43 les, specifically the simian virus 40 (SV40) T antigens and oncogenic Ras(12V), affect fatty acid met
44 n increase in unsialylated core 1 O-glycans (T-antigens) and Tn-antigens.
45 cin origin, with terminal fucose, the sialyl T-antigen, and N-linked oligosaccharides identified as p
46 me or all of the functions of the SV40 small T antigen, another well-characterized oncoprotein, in tw
47 cture of the hexameric helicase of JCV large T antigen (apo) and its use to drive the structure-based
48 tly focused on a few epitopes within variant TS antigens appear to neither contribute to, nor detract
49 ons of full-length and truncated MCPyV large T antigen are unknown.
50 criptase (hTERT) plus SV40 large T and small T antigens are transformed by either oncogenic Ras (H-Ra
51            These results indicate that MCPyV T antigens are tumorigenic in vivo, consistent with thei
52         We further show that the BKPyV large T antigen, as well as large T antigens from related poly
53 ecule and ensemble assays to show that large T antigen assembled on the SV40 origin unwinds DNA effic
54                        Reliable detection of TES antigen at 10 and 30 pg/mL level was demonstrated in
55 s long-terminal region-driven polyoma middle T antigen breast cancer model.
56                        By binding YAP, small t antigen brings it together with protein phosphatase 2A
57                                    JCV large T antigen, but not VP1 capsid protein, was expressed in
58 ere positive for early SV40 transcript large T antigen, but only 4 of the 14 cases exhibited late vir
59 uch as retinoblastoma (RB1) by mutated viral T antigens, but the molecular pathogenesis of MCPyV-nega
60 loping antibodies capable of detecting large T antigen by immunohistochemistry.
61   In contrast, expression of the MCPyV large T antigen C-terminal 100 residues could inhibit the grow
62 how that the oncogenes simian virus 40 large T antigen, c-Myc, and cyclin E induce spatial reorganiza
63    However, we have observed that SV40 large T antigen can induce cell proliferation and transformati
64                                The two small T antigens can target different proteins for dephosphory
65 ated a novel mouse hepatocellular SV40 large T-antigen carcinoma cell line, MHT that maintains the ab
66      The analysis of the mechanisms by which T antigen carries out its many functions has proved to b
67 erse transcriptase (hTERT) and/or SV40 large T antigen cDNA vectors, and antibiotic-resistant cells w
68 d anthracyclines were studied in CEA424/SV40 T-antigen (CEA/Tag) transgenic mice, which develop gastr
69 tion of p53 and Rb proteins using SV40 large T antigen completely rescued necrotic cell death.
70 he hexameric replicative helicase SV40 large T antigen, constituting a simple primosome that is activ
71                            On its own, small t antigen controls cell survival and differentiation.
72            Our results suggest that the SV40 T antigen could be a valuable tool to dissect cellular a
73                                  MCPyV large T antigen could bind to Rb but was unable to bind to p53
74 arious models are proposed to illustrate how T antigen could separate the central origin.
75  progeny than the wild type, suggesting that T antigen-CUL7-directed proteolysis facilitates virus pr
76 standards sequenced in this study with large T antigen deletions were cultured in cell lines immortal
77                        Mice expressing MCPyV T antigens developed hyperplasia, hyperkeratosis, and ac
78 ogenesis using an orthotopic, polyoma middle-T antigen-driven model in Foxp3(DTR) knockin mice.
79  form core 1 Galbeta1-3GalNAcalpha1-Ser/Thr (T antigen) during mucin type O-glycan biosynthesis.
80 cted to encode the large T antigen and small T antigen early proteins and the VP1, VP2, and VP3 struc
81 untranslated region (UTR) of the BPCV1 large T antigen early transcript and identified a functional m
82                     The large tumor antigen (T antigen) encoded by simian virus 40 is an amazing mole
83          Verhaegen et al. report MCPyV small T-antigen-expressing transgenic mice that now provide in
84 3 in the two MCC specimens that lacked large T antigen expression and in only 1 of 56 tumors positive
85 nvestigated any potential link between MCPyV T antigen expression and the highly metastatic nature of
86 rnative mechanisms of negative regulation of T antigen expression between the BPCVs and the polyomavi
87 agic acid and spiperone also inhibited large T antigen expression by BK virus and JC virus, two impor
88             These miRNAs negatively regulate T antigen expression by directing small interfering RNA
89 e have low mutation burden and require viral T antigen expression for tumor growth.
90 vel monoclonal antibody detected MCPyV large T antigen expression in 56 of 58 (97%) unique MCC tumors
91                                      Ectopic T antigen expression results in the immortalization and
92                          As a consequence of T antigen expression, B cells develop normally but, upon
93  an important role in regulating viral large-T-antigen expression and limiting the replication of arc
94 d from the late strand regulates viral large-T-antigen expression and limits the replication capacity
95       The biosensor was used to evaluate the T-antigen expression in serum samples and was able to di
96 rcentage of BKV infected cells and the large T-antigen expression were significantly decreased in HRP
97  BKV by immunofluorescent analysis and large T-antigen expression which suggested BKV infection by We
98 ols, which was not due to the suppression of T-antigen expression.
99 taining mutations in the C terminus of large T antigen fail to replicate efficiently or form plaques
100 sX abundance, (b) the fibronectin, collagen, T-antigen (FCT) region of the genome, which contains the
101 he deletion of the C terminus of MCPyV large T antigen found in MCC serves not only to disrupt viral
102  the BKPyV large T antigen, as well as large T antigens from related polyomaviruses, is alone capable
103     These residues are well conserved in the T antigens from the polyomaviruses, indicating that the
104  acid reading frame of opposing-strand large T antigen gene.
105 major capsid protein gene VP1, and the large T antigen gene.
106 to other polyomaviruses, MCPyV encodes early T antigen genes, viral oncogenes required for MCC tumor
107 utations were detected in both VP1 and large T antigen genes.
108 , rescues the minerva mutant's migration and T-antigen glycosylation defects.
109                     These data indicate that T antigen has a mechanism to specifically unwind the cen
110 68 (p68N) that physically interacts with the T antigen helicase domain.
111 cture of p68N and map its interface with the T antigen helicase domain.
112 ise molecular interactions between the viral T antigen, host replication proteins, including DNA poly
113 xP-flanked stop cassette, and the SV40 large T-antigen (iAST).
114                                              T-antigen immortalization of cells allowed cell growth.
115        Comparisons of polyoma and SV40 small T antigens implicate Abeta in the control of differentia
116                         We report that small T antigen in complex with MYCL and the EP400 complex act
117  gland tumors induced by polyomavirus middle T antigen in JNK2(-/-) mice were more sensitive to CDDP
118 the results of their efforts to express SV40 T antigen in mature B cells of mice.
119 re effective than full-length and 57kT large T antigen in promoting the growth of human and mouse fib
120 abel-free profiling of the cancer-associated T antigen in serum samples.
121 e novo by overprinting of the second exon of T antigen in the common ancestor of a large clade of mam
122 e used transgenic mice expressing SV40 large T antigen in their prostatic neuroendocrine cells, under
123 a viral oncogene that cooperates with middle T antigen in transformation.
124 inase expression induced expression of MCPyV T antigens in stratified squamous epithelial cells and M
125  the oncogenic activity of MCC tumor-derived T antigens in vivo, a conditional, tissue-specific mouse
126                            Here we show that T-antigen in Drosophila melanogaster macrophages is invo
127 growth factor alpha, but not simian virus 40 T-antigen, increase the rate of hepatocyte growth under
128  PP2A Abeta/Akt interaction by polyoma small T antigen increased turnover of Akt Ser-473 phosphorylat
129 s required for A3B induction by polyomavirus T antigen indicating a shared molecular mechanism.
130 polyomavirus (MCPyV)-derived truncated large T antigens induced ATOH1 expression in fibroblasts, whic
131  suggest an important role of UNC5B in small-T antigen-induced mitotic catastrophe that also requires
132 sformation of many cell types in culture and T antigen induces neoplasia when expressed in rodents.
133 p68N-T antigen affinity, confirming that p68-T antigen interaction is vital for primosome function.
134                                    For small T antigens, interaction with PP2A is needed for each of
135                           Polyomavirus small t antigen is a viral oncogene that cooperates with middl
136 genic mice in which expression of SV40 large T antigen is driven by UPK II promoter.
137                          Although SV40 large T antigen is essential, it is not sufficient for cellula
138                                              T antigen is required for viral DNA replication, transcr
139 m) in which an increase in the expression of T antigen is well-known.
140 l cell polyomavirus (MCPyV) expressing viral T antigens is a common feature of most Merkel cell carci
141 rant display of the truncated core1 O-glycan T-antigen is a common feature of human cancer cells that
142 he knockdown of Sox2 in MCV(+) MCCs mimicked T antigen knockdown by inducing MCC cell growth arrest a
143 uding HES6, SOX2, ATOH1, and KRT20 Of these, T antigen knockdown directly inhibited Sox2 and Atoh1 ex
144     Single-cell RNA sequencing revealed that T antigen knockdown inhibited cell cycle gene expression
145 as downregulated by the MCPyV early gene, as T antigen knockdown rescued the level of NDRG1.
146 ce that express a fragment of the SV40 small t antigen known to inhibit protein phosphatase 2A (PP2A)
147                            Higher macrophage T-antigen levels require an atypical major facilitator s
148  large probasin promoter directed SV40-large T-antigen (LPB-Tag) expressing mouse prostate, mPIN form
149 T antigen (ST) and a truncated form of large T antigen (LT) and usually contains wild-type p53 (TP53)
150 protein phosphatase 2A (PP2A), and the large T antigen (LT) binds pRb, p107, p130, and p53.
151 monstrated that simian virus 40 (SV40) large T antigen (LT) binds to the Bub1 kinase, a key regulator
152 t the co-crystal structure of the SV40 Large-T Antigen (LT) hexameric helicase bound to its origin ds
153 pended on the coexpression of the SV40 large T antigen (LT) in the cells.
154                 Simian virus 40 (SV40) large T antigen (LT) is a multifunctional protein that is impo
155                 Simian virus 40 (SV40) large T antigen (LT), for example, targets p53 directly, but m
156 inding and helicase domains of the MCV large T antigen (LT), suggesting a selective pressure to remov
157 t expression of simian virus 40 (SV40) large T antigen (LT), without a viral origin, is sufficient to
158 iated DDR pathways accumulate in MCPyV large T antigen (LT)-positive nuclear foci in cells infected w
159  t-antigen (ST) collaborates with SV40 large T-antigen (LT) and activated rasv12 to promote transform
160 ens, pharmacologic interference of the large T antigen (LTA) may represent an effective therapeutic a
161            Phylogenetic trees based on large T-antigen (LTA) allow separation of subtype I into subgr
162 e prostate model that is driven, in part, by T antigen-mediated functional inactivation of p53.
163                      Here we found that SV40 T antigen-mediated transformation inhibits HCMV infectio
164 enesis in ovariectomized polyomavirus middle T-antigen mice.
165 use mammary tumor virus-polyoma virus middle T antigen (MMTV-PyMT)-induced breast cancer to conduct s
166 the mouse mammary tumor virus-polyoma middle T-antigen model.
167 the Mouse Mammary Tumor Virus-Polyoma Middle T-Antigen mouse.
168 ssing SV40 large T antigen and the levels of T antigen mRNA were reduced in infected human and monkey
169 locks tumor formation in both polyoma middle T antigen (MT) and HER2/Neu transgenic models of breast
170 re we characterize YAP as a target of middle T antigen (MT) important for transformation.
171                   The gene coding for middle T antigen (MT) is the murine polyomavirus oncogene most
172                                       Middle T antigen (MT) is the primary polyomavirus oncogene resp
173 reast cancer driven by either polyoma middle T antigen (MT) or HER2 is p110alpha dependent.
174 d differentiation and cooperates with middle T antigen (MT) to transform primary cells in vitro and i
175                                       Middle T antigen (MT), the oncogene of polyomavirus, can drive
176                                       Middle T antigen (MT), the principal oncoprotein of murine poly
177 ialyl Lewis-X (sLe(X)) and the di-sialylated T-antigen (NeuAcalpha2,3Galbeta1,3(NeuAcalpha2,6)GalNAc)
178 cal monopartite NLSs, such as c-myc and SV40 T-antigen NLSs.
179 H was independently associated with JC virus T antigen (odds ratio [OR] = 1.93; P = .0077), body mass
180 ALTO is evolutionarily related to the middle T antigen of murine polyomavirus despite almost no seque
181 ic C subunit, in a manner similar to that of T antigens of the small DNA tumor viruses.
182        As in other polyomaviruses, the large T-antigen of MCV recognizes the viral origin of replicat
183 e studies uncover the action of polyomavirus T antigens on cellular CBP/p300 and suggest that additio
184 rmine that Minerva increases the presence of T-antigen on proteins in pathways previously linked to c
185            While the impact of MCV and viral T-antigens on MCC development has been extensively inves
186  in HER2/neu mice, but not in polyoma middle T-antigen oncomice.
187 cells on activation of either polyoma middle T antigen or ErbB2 signaling.
188 d in cells immortalized by either SV40 large T antigen or p53-null mutation, whereas alpha3beta1-depe
189 vity because of the expression of SV40 large T-antigen or because of a mutation in the TP53 gene.
190 of PP2A with okadaic acid, fostriecin, small T antigen, or PP2A knockdown abrogated rapamycin-induced
191  two highly constrained regions of the large T antigen ORF provided a start codon and C-terminal hydr
192 the 2.9 A crystal structure of the MCV large T-antigen origin binding domain (OBD) in complex with a
193  1 and minimal intrarenal expression of SV40-T antigen (P < 0.001).
194 ntigen, suggesting a functional link between T antigen-p68 interaction and primosome activity.
195  of p68 residues in the interface diminished T antigen-p68 interaction, confirming the interaction si
196           Here, we report the detailed large T antigen-p68 interface, as revealed in a co-crystal str
197 ell lines show oncogene addiction to the MCV T antigens, pharmacologic interference of the large T an
198 case domains of simian virus 40 (SV40) large T antigen play a critical role in DNA replication.
199 ferences between SVST and polyomavirus small T antigen (POLST) in their effects on differentiation, t
200  prototypical NLS from simian virus 40 large T-antigen preferentially at the major NLS binding site.
201 sis on the cell-cell modules that complement T-antigen-presenting cell interaction, provides a fundam
202 ns with the unique T. cruzi trans-sialidase (TS) antigen protect against gastric and systemic T. cruz
203 isms were detected in the VP1, VP2 and Large T Antigen proteins, suggesting potential functional effe
204                Using the MMTV-Polyoma Middle T antigen (PyMT) mouse model of human ductal carcinoma,
205                      The polyomavirus middle T antigen (PyMT) oncogene activates the cellular nonrece
206 mary tumor virus (MMTV)-Polyoma virus middle T antigen (PyMT) or MMTV-c-Neu transgenic mice.
207 mmary tumorigenesis using the polyoma middle T antigen (PyMT) transgenic mouse model.
208 metastatic breast cancer, the polyoma middle T antigen (PyMT) transgenic mouse.
209                        In the polyoma middle T-antigen (PyMT) transgenic mouse model of breast cancer
210  have utilized the murine polyomavirus small T antigen (PyST) as a tool to study UNC5B-mediated apopt
211                    Murine polyomavirus small t antigen (PyST) regulates cell cycle, cell survival, ap
212                                Polyoma small T antigen (PyST), an early gene product of the polyoma v
213                        Like all polyomavirus T antigens, PyST functions largely via its interactions
214                         Polyoma virus middle T antigen (PyVmT) is a powerful viral oncogene; however,
215 ncluding the widely used polyomavirus middle-T antigen (PyVmT) model, which provides an opportunity t
216 ctively, due to large deletions in the large T antigen region.
217 of miRNA-mediated negative regulation of the T antigens remains uncertain.
218 suppressor p53 and pRb in urothelium by SV40 T antigen resulted in urothelial carcinoma, resembling h
219 nslocation strand, suggesting that the large T antigen ring can open to bypass bulky adducts.
220 g peptide (LPLMRKAYL), encoded by 2 relevant T-antigens (small T and large T) and previously shown to
221 is the most sensitive method to quantify the TES antigen so far.
222              Fabpi-TAg mice expressing large T-antigen solely in villi had ectopic enterocyte prolife
223             MCV-positive MCC expresses small T antigen (ST) and a truncated form of large T antigen (
224                              The MWPyV small T antigen (ST) binds protein phosphatase 2A (PP2A), and
225 ecently demonstrated that polyomavirus small T antigen (ST) binds YAP, a major effector of Hippo sign
226     We have previously shown that SV40 small t antigen (st) cooperates with deregulated cyclin E to a
227                                   SV40 small t antigen (ST) has been reported to be necessary and suf
228         Merkel cell polyomavirus (MCV) small T antigen (sT) is the main oncoprotein for the developme
229 t of regulatory B subunits by the SV40 Small T antigen (ST) or mutation/deletion of PP2A subunits alt
230                   Coexpression of SV40 small t antigen (st), but not other tested oncogenes, efficien
231 e of the functions of the polyomavirus small T antigens (ST) are shared by the E6 and E7 oncoproteins
232                                   SV40 small t-antigen (ST) collaborates with SV40 large T-antigen (L
233 ress putative polyomavirus oncoprotein small T antigen (sTAg) and truncated large T antigen.
234 nds directly to the hexameric viral helicase T antigen, suggesting a functional link between T antige
235 es immortalized using simian virus 40 (SV40) T antigen, suggesting the possibility of transcomplement
236 hereas immortalization induced by SV40 large T antigen supported fibroblast proliferation in the abse
237                                   SV40 small T antigen (SVST) has received considerable attention bec
238                 Simian virus 40 (SV40) large T antigen (SVT) interferes with normal cell regulation a
239  promoter to target expression of SV40 large T-antigen (T-Ag) in the undifferentiated murine embryoni
240 domain (OBD) of simian virus 40 (SV40) large T-antigen (T-Ag) is essential for many of T-Ag's interac
241 rototypical replicative helicase, SV40 large T-antigen (T-ag), was investigated.
242 nity binding element for the viral initiator T-antigen (T-ag).
243 o address this question, we knocked down MCV T-antigen (TA) expression in MCV-positive MCC cell lines
244 r suppressor p53 (fused to Gal4BD) and large T antigen (TAg) (fused to VP16) was visualized in vivo b
245  the input virus nor the expression of large T antigen (TAg) alone is sufficient to trigger the activ
246 lleles, including the simian virus 40 (SV40) T antigen (TAg) and oncogenic H-Ras, inhibit HCMV infect
247                        Simian virus 40 large T antigen (TAg) contributes to cell transformation, in p
248  and emphasized the importance of functional T antigen (Tag) for efficient replication.
249                        Simian virus 40 large T antigen (TAg) transforms cells in culture and induces
250 seeding of tumorigenic hepatocytes from SV40 T antigen (Tag) transgenic MTD2 mice into the livers of
251 on, persistent overexpression of viral large T antigen (TAg), and malignancy, yet little is known abo
252  origin and flanking sequences, to which BKV T antigen (Tag), cellular proteins, and small regulatory
253 duced activation of the oncogenic SV40 large T antigen (TAg).
254      In agreement, expression of large tumor T antigens (TAg) encoded by polyomaviruses in mammalian
255 feron gamma (IFNgamma) induction of the SV40 T-antigen (TAg) was assayed by immunohistochemistry and
256                                 In addition, T antigen targets multiple cellular pathways, including
257         Mutations in the C terminus of large T antigen that disrupt binding to the host protein FAM11
258 ns result in expression of a truncated large T antigen that retains the Rb binding or LXCXE motif but
259 ng discovered provides a collection of novel T antigens that, like simian virus 40, can be used to di
260 sis of the common core 1 O-glycan structure (T-antigen), the precursor structure for most mucin-type
261 ormation assay that also includes SV40 large T antigen, the catalytic subunit of cellular telomerase,
262                           By contrast, large T antigen, the replicative DNA helicase of the simian vi
263 lization via genetic influences such as SV40 T-antigen, thus limiting our knowledge of the events tha
264 evels of SnoN cooperated with polyoma middle T antigen to accelerate the formation of aggressive mult
265 te (TRAMP) model of PCa that uses SV40 large T antigen to induce PCa, loss of Foxm1 decreased tumor g
266 ggest that additional mechanisms are used by T antigens to induce cell immortalization and transforma
267 defined oncogenic driver antigen (SV40 large T-antigen) to follow the activation and differentiation
268  BPCV1 miRNA is not encoded antisense to the T antigen transcripts but rather lies in a separate, pro
269 preserving the reading frame of the opposing T antigen transcripts.
270 , but were the cell line 661W, a mouse SV-40 T antigen transformed photoreceptor cell line.
271  selectively induces apoptosis of SV40 large T-antigen transformed cells and significantly reduces co
272 contrast to the half-life of simian virus 40 T antigen-transformed cells.
273                                 In contrast, T-antigen-transformed REF52 and p53+/+ HCT116 tumor cell
274 hrelinomas induced by a tissue-specific SV40 T-antigen transgene.
275              MATERIALS AND C3(1) Sv-40 large T antigen transgenic mice (n = 23) were studied with ins
276 eighted (DW)-MRI in the polyoma virus middle T antigen transgenic mouse model of breast cancer.
277 by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited
278 ination is a secondary occurrence, following T antigen-triggered oligodendroglial apoptosis.
279               Mice expressing Polyoma middle T antigen under the mouse mammary tumor virus promoter w
280 mouse prostate (TRAMP) mice express the SV40 T-antigen under the control of the probasin promoter, an
281                             Stimulation with TD antigens under inflammatory conditions induces plasma
282 e, and Tregs are produced in the presence of TD antigens under tolerance conditions.
283                          Unexpectedly, large T antigen unwinds DNA past a DNA-protein crosslink on th
284 died these mutants to gain insights into how T antigen unwinds the origin.
285 these controversies, we detected MCPyV large T antigen using immunohistochemistry with two distinct a
286 selective detection of the cancer-associated T antigen, using the lectin from Arachis hypogaea (peanu
287              The occurrence of T- and sialyl T-antigen varied in bovine and ovine reproductive tract
288 on induced by Merkel cell polyomavirus small T antigen viral oncoprotein.
289                In support of this, wild-type T antigen was able to specifically unwind a 31-bp DNA co
290                                  While large T antigen was expressed to higher levels in adar1(-/-) c
291           Furthermore, MCPyV-truncated large T antigen was more effective than full-length and 57kT l
292 aperone, since simian immunodeficiency virus T antigen was previously shown to contain a J domain; ho
293 ombination, transforming growth factor alpha/T-antigen, was sufficient to direct cell autonomous grow
294                However, JCV proteins (VP1 or T antigen) were detected mainly in the brains of 23/24 H
295 al oncoprotein, simian virus 40 (SV40) large T-antigen, which is frequently used to immortalize cells
296 his work shows how this association of small t antigen with YAP is important for its effects on cell
297 MWPyV is a widespread human virus expressing T antigens with low transforming potential.
298 roteins, by replacing SV40 large T and small T antigens with sh-p53, mutant CDK4 (CDK4(R24C)), and sh
299  to plasma cells in response to T-dependent (TD) antigens within germinal centers (GCs).
300          In contrast, tolerance induction by TD antigens without costimulation triggers the developme

 
Page Top